Search

everythinglearnresearchcommunity

for

Search:↓

ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Consider benefits and risks of new alopecia treatments for safety.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.

The nanoparticle-emulsion with polihexanide is more effective and lasts longer for skin antisepsis.

Using micro-needling, low-level laser therapy, and platelet-rich plasma together significantly improves hair growth in people with hair loss.

Mice with autoimmune hair loss showed signs of heart problems.

Use PRP and ASC-BT for hair loss and wound healing, but more research needed.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

The document concludes that careful surgical methods and choosing the right materials are key for successful scalp, skull, and frontal sinus reconstruction.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

FDA-cleared devices may help treat hair loss, but more research needed; consult dermatologist before use.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

Scientists can grow human hair follicle stem cells in a lab without changing their nature, which could help treat hair loss.

Gene therapy shows promise for enhancing physical traits but faces ethical, safety, and regulatory challenges.

Adipose tissue shows promise for hair regrowth, but more research is needed to confirm best practices and effectiveness.

Platelet Rich Plasma (PRP) shows promise for tissue repair and immune response, but more research is needed to fully understand it and optimize its use.

Retinoids can prevent skin cancer in high-risk people but have side effects and require more research on dosing and effectiveness.

The document concludes that hair loss is common and can be treated with medications like minoxidil or surgical options, and it significantly affects people's psychological well-being.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Eating selenium-rich rice improved antioxidant activity and signs of aging in mice.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The document concludes that changes in eyelashes and eyelid skin can indicate various local and systemic diseases.

A new skin disease in four Labrador retrievers responded well to immunosuppressive treatment.